Hamilton Wealth’s Biogen BIIB Stock Holding History

Hamilton Wealth’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-8,579	Closed	-$2.03M	–	44
2019 Q1	$2.03M	Buy	8,579 +556	+7%	+$175K	1.61%	22
2018 Q4	$2.41M	Buy	+8,023	New	+$2.56M	2.36%	14

Other funds holding BIIB

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Hamilton Wealth's BIIB Position: Q2 2019 in Review

Hamilton Wealth sold out of Biogen (BIIB) in Q2 2019, closing a stake of 8,579 shares — an estimated $2.03M sold.

Hamilton Wealth first reported a position in BIIB in Q4 2018 and held it in 2 quarters. The position peaked at $2.41M in Q4 2018. 1,010 funds tracked by Wall St. Rank hold BIIB as of Q2 2019.

Hamilton Wealth reported no remaining Biogen position as of Q2 2019 after selling out during the quarter.
Hamilton Wealth sold 8,579 Biogen shares in Q2 2019, an estimated $2.03M.
Hamilton Wealth first reported a position in Biogen in Q4 2018 and held it in 2 quarters.
Hamilton Wealth's Biogen position peaked at $2.41M in Q4 2018.
1,010 funds tracked by Wall St. Rank held Biogen as of Q2 2019.

Based on Hamilton Wealth's 13F filing for Q2 2019, filed 6 Aug 2019.